CIRCCa: A Randomised Double Blind Phase II Trial of Carboplatin-Paclitaxel Plus Cediranib Versus Carboplatin-Paclitaxel Plus Placebo in Metastatic/Recurrent Cervical Cancer

Authors
Category Primary study
ConferenceESMO Congress; 2014 Sep 26-30; Madrid, Spain. Annals of Oncology
Year 2014
This article has no abstract
Epistemonikos ID: 552ad18b3eb98f8a2cc2ff2ec5c18557f079801a
First added on: Aug 02, 2019